Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 6734

Sort by

Sort Order Select

Journal Articles

Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes

Rami Komrokji, Virginia Volpe, Onyee Chan, Najla Al Ali, David Swoboda, Andrew Kuykendall, Eric Padron, David A. Sallman

Blood (2021) 138 (11): 989–992.

https://doi.org/10.1182/blood.2021010831

Published: 2021

Journal Articles

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Blood (2021) 138 (10): 898–911.

https://doi.org/10.1182/blood.2021011075

Published: 2021

Includes: Supplemental data

Journal Articles

The journey of a thousand miles begins with 1 step

Luca Malcovati

Blood (2021) 138 (10): 824–826.

https://doi.org/10.1182/blood.2021012304

Published: 2021

Journal Articles

Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in a large-scale cohort study

Anke Neumann, Marie-Joelle Jabagi, Mahmoud Zureik

Blood (2021) 138 (5): 417–420.

https://doi.org/10.1182/blood.2021010848

Published: 2021

Includes: Supplemental data

Journal Articles

Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia

Caiying Zhu, Yu Lian, Chenchen Wang, Peng Wu, Xuan Li, Yan Gao, Sibin Fan, Lanlan Ai, Liwei Fang, Hong Pan, Tao Cheng, Jun Shi, Ping Zhu

Blood (2021) 138 (1): 23–33.

https://doi.org/10.1182/blood.2020008966

Published: 2021

Includes: Supplemental data

Journal Articles

Therapeutic options in VEXAS syndrome: insights from a retrospective series

Estelle Bourbon, Maël Heiblig, Mathieu Gerfaud Valentin, Thomas Barba, Cécile-Audrey Durel, Jean Christophe Lega, Fiorenza Barraco, Pascal Sève, Yvan Jamilloux, Pierre Sujobert

Blood (2021) 137 (26): 3682–3684.

https://doi.org/10.1182/blood.2020010177

Published: 2021

Includes: Supplemental data

Journal Articles

Vacuolization of hematopoietic precursors: an enigma with multiple etiologies

Carmelo Gurnari, Simona Pagliuca, Lisa Durkin, Laila Terkawi, Hassan Awada, Sunisa Kongkiatkamon, Misam Zawit, Eric D. Hsi, Hetty E. Carraway, Heesun J. Rogers, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2021) 137 (26): 3685–3689.

https://doi.org/10.1182/blood.2021010811

Published: 2021

Includes: Supplemental data

Journal Articles

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Lisa Giulino-Roth, Qinglin Pei, Allen Buxton, Rizvan Bush, Yue Wu, Suzanne L. Wolden, Louis S. Constine, Kara M. Kelly, Cindy L. Schwartz, Debra L. Friedman

Blood (2021) 137 (11): 1449–1456.

https://doi.org/10.1182/blood.2020007225

Published: 2021

Includes: Supplemental data

Journal Articles

How I treat warm autoimmune hemolytic anemia

Wilma Barcellini, Bruno Fattizzo

Blood (2021) 137 (10): 1283–1294.

https://doi.org/10.1182/blood.2019003808

Published: 2021

Journal Articles

Absence of a common founder mutation in patients with cooccurring myelodysplastic syndrome and plasma cell disorder

Monika Klimkowska, Yasuhito Nannya, Charlotte Gran, Robert Månsson, Iyadh Douagi, Seishi Ogawa, Hareth Nahi, Magnus Tobiasson

Blood (2021) 137 (9): 1260–1263.

https://doi.org/10.1182/blood.2020007555

Published: 2021

Includes: Supplemental data

Journal Articles

Myelodysplastic syndrome with ring sideroblasts presenting as postmediastinal extramedullary hematopoiesis

Tsugumi Satoh, Hidekazu Kayano

Blood (2020) 136 (10): 1213.

https://doi.org/10.1182/blood.2020006260

Published: 2020

Journal Articles

Somatic genetic rescue in hematopoietic cells in GATA2 deficiency

Luiz Fernando B. Catto, Gustavo Borges, André L. Pinto, Diego V. Clé, Fernando Chahud, Barbara A. Santana, Flavia S. Donaires, Rodrigo T. Calado

Blood (2020) 136 (8): 1002–1005.

https://doi.org/10.1182/blood.2020005538

Published: 2020

Includes: Supplemental data

Journal Articles

Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study

Guillermo Garcia-Manero, Elizabeth A. Griffiths, David P. Steensma, Gail J. Roboz, Richard Wells, James McCloskey, II, Olatoyosi Odenike, Amy E. DeZern, Karen Yee, Lambert Busque, Casey O’Connell, Laura C. Michaelis, Joseph Brandwein, Hagop Kantarjian, Aram Oganesian, Mohammad Azab, Michael R. Savona

Blood (2020) 136 (6): 674–683.

https://doi.org/10.1182/blood.2019004143

Published: 2020

Journal Articles

SF3B1 -mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

Blood (2020) 136 (2): 157–170.

https://doi.org/10.1182/blood.2020004850

Published: 2020

Journal Articles

Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria

Lova Sun, Daria V. Babushok

Blood (2020) 136 (1): 36–49.

https://doi.org/10.1182/blood.2019000940

Published: 2020

Journal Articles

SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS

Blood (2020) 135 (25): 2271–2285.

https://doi.org/10.1182/blood.2019001963

Published: 2020

Includes: Supplemental data

Journal Articles

Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug–induced thrombocytopenia

Taro Tochigi, Toshihiro Miyamoto, Kiwamu Hatakeyama, Teppei Sakoda, Daisuke Ishihara, Hidetoshi Irifune, Takahiro Shima, Koji Kato, Takahiro Maeda, Takumi Ito, Hiroshi Handa, Koichi Akashi, Yoshikane Kikushige

Blood (2020) 135 (24): 2146–2158.

https://doi.org/10.1182/blood.2019003749

Published: 2020

Includes: Supplemental data

Journal Articles

Cancer spectrum and outcomes in the Mendelian short telomere syndromes

Kristen E. Schratz, Lisa Haley, Sonye K. Danoff, Amanda L. Blackford, Amy E. DeZern, Christopher D. Gocke, Amy S. Duffield, Mary Armanios

Blood (2020) 135 (22): 1946–1956.

https://doi.org/10.1182/blood.2019003264

Published: 2020

Includes: Supplemental data

Journal Articles

Erdheim-Chester disease

Julien Haroche, Fleur Cohen-Aubart, Zahir Amoura

Blood (2020) 135 (16): 1311–1318.

https://doi.org/10.1182/blood.2019002766

Published: 2020

Journal Articles

Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies

Daniel Sasca, Haiyang Yun, George Giotopoulos, Jakub Szybinski, Theo Evan, Nicola K. Wilson, Moritz Gerstung, Paolo Gallipoli, Anthony R. Green, Robert Hills, Nigel Russell, Cameron S. Osborne, Elli Papaemmanuil, Berthold Göttgens, Peter Campbell, Brian J. P. Huntly

Blood (2019) 134 (24): 2195–2208.

https://doi.org/10.1182/blood.2019001553

Published: 2019

Includes: Supplemental data

NARROW

Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes

The clinical and functional effects of TERT variants in myelodysplastic syndrome

The journey of a thousand miles begins with 1 step

Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in a large-scale cohort study

Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia

Therapeutic options in VEXAS syndrome: insights from a retrospective series

Vacuolization of hematopoietic precursors: an enigma with multiple etiologies

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

How I treat warm autoimmune hemolytic anemia

Absence of a common founder mutation in patients with cooccurring myelodysplastic syndrome and plasma cell disorder

Myelodysplastic syndrome with ring sideroblasts presenting as postmediastinal extramedullary hematopoiesis

Somatic genetic rescue in hematopoietic cells in GATA2 deficiency

Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study

SF3B1 -mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria

SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS

Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug–induced thrombocytopenia

Cancer spectrum and outcomes in the Mendelian short telomere syndromes

Erdheim-Chester disease

Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only